|
ZEPOSIA
Filed on: 11/18/2019
|
Pharmaceutical preparations for use in the treatment of autoimmune disease, multiple sclerosis and ulcerative colitis
read more...
|
REGISTERED
12/7/2021
|
|
|
ZEPOSIA
Filed on: 3/31/2016
|
Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitor...
read more...
|
CONTINUED USE AND INCONTESTIBILITY ACCEPTED
7/19/2023
|
|
|
ZEPOSIA 360 SUPPORT
Filed on: 11/20/2019
|
Administration of patient reimbursement programs in connection ozanimod; administering pharmacy reimbursement programs and services in connection ozanimod
read more...
|
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
10/2/2020
|
|
|
ZEPOSIA ONCE-DAILY OZANIMOD
Filed on: 10/5/2021
|
Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitor...
read more...
|
NOTICE OF ALLOWANCE - ISSUED
1/2/2024
|
|